ITCC-064 ABT 414
ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
Promotor Name : ABBVIE
Investigator Name : D. HARGRAVE
Trial registered on clinicaltrial.gov: NCT02343406
